Back to Market返回行情

LABU Direxion Daily S&P Biotech Bull 3X Shares

AMEXETF
$293.60-9.46%OpenAssets: $1.57B

As of 2026-07-10 13:44

Why LABU matters now

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is a US etf in Financial Services. The latest InvestLog snapshot shows $293.60 with -9.46% on the session and $1.57B in assets/market value.

The latest indexable market news headline is "LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout" from 24/7 Wall Street.

ETF Profile

Updated 2026-07-09

Net Assets

$737.9M

NAV

$317.44

Expense Ratio

0.96%

Holdings

156

Issuer

Direxion

Asset Class

Equity

Avg Volume

579,798

Inception

2015-05-28

Sector Exposure

Financial Services0.33%
Healthcare99.67%

Top Holdings

SymbolNameWeightMarket Value
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP72.21%$1.92B
DREYFUS GOVT CASH MAN INS7.65%$203.9M
GOLDMAN FINL SQ TRSRY INST 5064.86%$129.5M
GOLDMAN SACHS FIN GOV 465 INSTITUT1.69%$45.1M
DREYFUS TRSRY SECURITIES CASH MGMT0.87%$23.1M
MRNAMODERNA INC0.19%$5.0M
APGEAPOGEE THERAPEUTICS INC0.18%$4.9M
KYMRKYMERA THERAPEUTICS INC0.17%$4.6M
VKTXVIKING THERAPEUTICS INC0.17%$4.5M
ERASERASCA INC0.16%$4.3M

Fund Info

Asset Type

ETF

Exchange

AMEX

Currency

USD

Issuer

Direxion

Asset Class

Equity

NAV Currency

USD

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x the daily performance of the S&P Biotechnology Select Industry Index. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF was formed on May 28, 2015 and is domiciled in the United States.